A protease produced by Vibrio mimicus was purified to apparent homogeneity by ammonium sulfate fractionation and successive column chromatography on Sephacryl S-100 and Mono Q Monobeads. The sodium dodecyl sulfate-polyacrylamide gel electrophoresis (PAGE) of the final preparation of the enzyme revealed the homogeneity of the purified enzyme. Conventional PAGE showed that the purified protease migrated as a single band with protease activity. The molecular weight of the protease was estimated to be about 31,000 on the basis of its mobility on sodium dodecyl sulfate-PAGE. The purified protease had both proteolytic and hemagglutination (HA) activities. The proteolytic and HA activities were inhibited by metalloprotease inhibitors and heat treatment. V. mimicus protease therefore appeared as a heat-labile, bifunctional molecule capable of mediating proteolysis and HA. The immunodiffusion analysis showed that the proteases produced by Vibrio cholerae and V. mimicus are immunologically cross-reactive.
Vibrio mimicus, an aquatic microflora (4), has been found to be responsible for various types of human illness. V. mimicus has been recognized as an agent for enteric infections (8, 22) and has also been found to be associated with various extraintestinal infections, viz., otitis media and wound infections (8) . Several investigators have reported the production of various toxins and toxic substances by V. mimicus strains, including cholera toxin (3. 25) , cholera toxin-related enterotoxins (9) , and Escherichia coli heatlabile or heat-stable enterotoxin-like toxins (13, 21) . The capability of colonization of rabbit small intestine by V. mimicus has been demonstrated by Spira et al. (26) , but the factor responsible for colonization has not been described. It has been reported that a metalloprotease in Vibrio cholerae culture filtrates enhanced the activity of cholera enterotoxin in intestinal loops by eroding the protective layer of epithelial mucus (5) . Such protease activity may facilitate bacterial intestinal colonization or detachment (or both) and enhance toxic activity. The purified soluble hemagglutinin (HA) produced by V. cholerae has been shown to be a bifunctional molecule capable of mediating hemagglutination and proteolysis (11, 14) . Investigators also observed that the purified HA plays a role in attachment of V. cholerae to rabbit small intestine (11, 16) . On the other hand, recent investigations demonstrated that there is no definite correlation between the cell-associated HA and the intestinal adhesion indices (6) . The V. cholerae HA/protease has also been reported to be responsible for the nicking and activation of cholera toxin (1) . It has been speculated that, like V. cholerae, V. mimicus may also produce an extracellular HA/protease (9), but purification of the molecule has not been attempted. Therefore, the present study was performed to purify and characterize protease produced by V. mimicus.
V. mimicus E-33, isolated from an aquatic environment as described previously (4) , was used for the study. About 107 bacteria were cultured in 1 liter of heart infusion broth (Difco Laboratories, Detroit, Mich.) with shaking for 24 h in a 37°C water bath. Antiserum to V. cholerae non-O1 protease was Inc. (Minoh, Japan). EDTA, ethylene glycol-bis(P-aminoethylether)-N,N,N',N'-tetraacetic acid (EGTA), and o-phenanthroline were purchased from Nakarai Tesque Ltd. (Kyoto, Japan). Tetraethylenepentamine (TEP) was obtained from Tokyo Kasei Kogyo Co. Ltd. (Tokyo, Japan).
Protease activity was determined with azocasein (Sigma Co., St. Louis, Mo.) as a substrate by a modified procedure described by Kreger and Lockwood (17) . The reaction mixture, consisting of 0.2 ml of azocasein solution (5 mg/ml) and 0.4 ml of protease preparation in 50 mM Tris-HCl buffer (pH 8.0) was incubated for 30 min at 37°C in a water bath. The reaction was stopped by the addition of 1.4 ml of 5% trichloracetic acid. After centrifugation at 1,000 x g for 5 min, 1 ml of the supernatant was mixed with the same volume of 0.5 M NaOH and the optical density was determined at 440 nm. One protease unit was defined as the amount which hydrolyzed 1 The partially purified protease was adjusted to pH 8.5 and applied to a Mono Q column (0.5 by 5 cm), which is an anion-exchange column (Pharmacia LKB) equilibrated with 20 mM Tris-HCI buffer (pH 8.5) in a fast protein liquid chromatographic system (FPLC) (Pharmacia). The column was eluted with a linear gradient of 0 to 0.5 M NaCl in the same buffer. The fractions containing protease activity were collected and stored as purified V. mimicus protease (VMP).
Conventional polyacrylamide gel electrophoresis (PAGE) was carried out by the method of Davis (7). To demonstrate the protease activity of the migrated protease band, one gel was embedded in 4% skim milk (Difco) agar (23) and incubated at 37°C for 24 h. The homogeneity of the final protease preparation was monitored by using sodium dodecyl sulfate (SDS)-PAGE as described by Laemmli (18) . The molecular weight of the protease was estimated on the basis of its mobility on SDS-PAGE.
The amount of protein in different stages of protease preparation was determined by the method described by Lowry et al. (19) .
The technique for HA assay was adapted from the method of Jones et al. (16) . Protease preparations were diluted in twofold series in round-bottom microtiter plates in 25 ,ul of Krebs-Ringer buffer (12) . Chicken erythrocytes, at a concentration of 1.5%, were prepared in the same buffer and were added in 25-,u portions, the plates were tapped to mix the interactants, and erythrocytes were allowed to settle at 25°C for 30 min. The titer was defined as the reciprocal of the highest dilution in which hemagglutination was visible to the naked eye. HA assay was also performed with erythrocytes from different species, viz., bovine, sheep, and human (type 0), by following the procedure described above.
The effect of heat treatment on the protease activity of the purified molecule was examined by heating the sample at 60, 75, and 100°C for 15 min (each) in 50 mM Tris-HCl buffer (pH 8.0). Protease and HA activities of heat-treated samples (final concentration, 1,ug) were determined as described above.
The effects of protease inhibitors were tested by adding various amounts of the following inhibitors to 1 jig of the VMP in 0.2 ml of 50 mM Tris-HCl buffer (pH 8.0): leupeptin, antipain, chymostatin, elastatinal (serine-cysteine-protease inhibitors), pepstatin A (aspartic-protease inhibitor), and phosphoramidon (metalloprotease inhibitor). After incubation for 30 min in a 37°C water bath, residual activity against azocasein was measured and the 50% inhibitory concentration was estimated. To test the effects of different metal ions on VMP, 1 ,ug of VMP was incubated with 0.2 ml of 2 mM metal ions in 50 mM Tris-HCl buffer (pH 8.0) for 30 min in a 37°C water bath. The metal ions used included MgCl2, CaCl2, MnCI2, FeCl2, NiCl2, CuCI,, ZnCI2, BaCl2, HgCI2, and PbCl2. After incubation, the protease activity was assayed as described above. The effects of chelating agents such as EDTA, EGTA, o-phenanthroline, and TEP on VMP were also examined following the same procedure described for metal ions, and the residual VMP activity against azocasein was assayed.
The VMP was inactivated with TEP as described above. To reactivate the VMP by removing the chelating agent, the mixture was applied to a Sephadex G-25 column (0.6 by 4.5 cm). The column was eluted with 50 mM Tris-HCl buffer (pH 8.0). Chelating agent-free column fraction was treated with 2 mM metal ions, and the restored activity against azocasein was measured as described above.
The amino acid analysis was performed by the procedure described by Spackman et al. (24) . VMP (ca. 1 mg) was hydrolyzed for 22 h at 110°C with 6 N HCl in vacuo. The analysis was performed with a JLC-300 amino acid analyzer (JEOL Ltd., Tokyo, Japan). The tryptophan content was estimated by the previously described spectroscopic method (10) .
Antiserum against VMP was produced in a Japanese rabbit with immunogen (400 to 800,ug) mixed with an equal volume of Freund complete adjuvant (Difco) injected three times subcutaneously in multiple sites at 15-day intervals. Finally, 1 mg of the immunogen was injected through footpads. After 1 week of rest, the rabbit was bled by cardiac puncture, and the serum was separated, pooled, and stored at -70°C.
The double-gel diffusion test was performed in 0.7% Noble agar (Difco) in 10 mM Tris-HCI buffer (pH 7.5) as described elsewhere (15) .
A typical Sephacryl S-100 column chromatogram of the VMP preparation is shown in Fig. 1 . The fractions containing protease activity (indicated by a bar in Fig. 1 Table 1 . Conventional PAGE of the purified VMP demonstrates that the protease activity is associated with the purified protein (Fig. 2) . The protease preparation that was obtained revealed homogeneity on disc electrophoresis in 12.5% PAGE containing 0.1% SDS (Fig. 2) , and thus, the VMP preparation was used as a purified molecule in further investigations.
The protease has been assumed to play a role in nicking and activating cholera toxin after it has been secreted (1).
The existence of such a protease produced by V. mimicus had been suspected (9) , but purification of the molecule had not been done. The protease activity in repeated preparations was found from the descending region of the void peak to a peak activity at the ascending region of the second peak (Fig. 1) . From the pattern of SephacrylS-100 column chromatography, we speculate that the VMP is a monomeric rather than a polymeric molecule unlike that of V. cholerae (11) . However, we do not exclude the possibility of an oligomeric form of the protease, since an oligomer of a protein could be eluted as a monomer after the void peak because of interaction with other proteins or with the col- b The specific activity of concentrated CS was taken as the standard and assigned the value of 1.
The total activity of concentrated CS was assigned the value of 1001%., and the total activity from each step was compared with the CS total activity.
d Prepared from 1 liter of heart infusion broth culture, as described in the text.
umn. The molecular mass appeared to be 31 kDa, a molecular size close to that of V. cholerae protease (VCP) (14) , on the basis of VMP mobility on SDS-PAGE. Purification to apparent homogeneity of a protease produced by V. mimicus was achieved in this study.
The purified VMP possessed hemagglutination activity; the minimum amounts of the molecule required to mediate proteolysis and hemagglutination were 1.0 and 3.0 p.g/ml, respectively. Among the erythrocytes from different species tested, VMP was found to agglutinate only erythrocytes from chickens with an HA titer of 16 . It appeared that like 01 or non-O1 VCP (11, 14) , VMP showed hemagglutination activity. Moreover, the proteolytic and HA activities were inactivated under the same condition of heat treatment. Therefore, V. mimicus also produces a bifunctional molecule capable of mediating proteolysis and hemagglutination.
The protease and HA activities were inhibited by a metalloprotease inhibitor, phosphoramidon, but not by serinecysteine-protease inhibitors or aspartic-protease inhibitors. The effects of metal ions and chelating agents on the proteolytic activity were examined. Among the metal ions tested, proteolytic activity was abolished completely by Cu2", throline and TEP inactivated proteolytic and HA activities completely, and EDTA and EGTA inactivated the activities partially. The TEP-inactivated protease was reactivated by the addition of Zn2+ and Mn2". Therefore, the results suggest that V. mimicus, like other Vibrio species (11, 20) , produces a metalloprotease and that Zn2+ and/or Fe2+ are essential for the activity of the enzyme. It is notable that the TEP-inactivated VMP was reactivated by Mn2 , indicating that the essential metal ions required for the activity of the molecule are replaceable.
The amino acid composition of the purified VMP was analyzed ( Table 2 ). The amino acid composition of VCP has been documented (Table 2 ) (11); however, the total number of residues was 212, which cannot be true for a protein of 32 kDa. We have recalculated the published composition of VCP to make corrections of the miscalculated values, and the composition of VMP appeared to have similarity with that of VCP. The percent compositions of glycine, alanine, and methionine appeared higher and those of phenylalanine, arginine, and tryptophan appeared slightly lower in the case of VMP when compared with that of V. cholerae (11) .
The double-gel diffusion test showed that the crude and purified VMP formed fused precipitin lines with the antisera against VMP and nonagglutinable vibrio proteases (Fig. 3) . Therefore, the VMP appeared to be immunologically crossreactive with non-01 VCP.
We have not examined the role of the VMP in V. mimicus gastroenteritis; by analogy to the 01 VCP (2, 5, 11), we could speculate that VMP serves as an enhancer of bacterial colonization by its proteolytic activity. V. mimicus has been reported to produce cholera toxin-like toxin (3, 21) , and therefore, like VCP (1), VMP may also play a role in nicking and activating enterotoxins produced by the pathogen. The precise role of the VMP in V. mimicus infections is under investigation in our laboratory.
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